Spots Global Cancer Trial Database for A Study of Emapalumab for Pediatric Aplastic Anemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Emapalumab for Pediatric Aplastic Anemia
Official Title: Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Study ID: NCT06430788
Interventions
Study Description
Brief Summary: The purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectiveness of standard treatment options.
Detailed Description:
Eligibility
Minimum Age: 0 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Cincinnati Children's Hospital Medical Center (Data collection only), Cincinnati, Ohio, United States
Children's Hospital of Philadelphia (Data Collection AND Specimen Analysis), Philadelphia, Pennsylvania, United States
Virginia Commonwealth Univeristy (Data Collection Only ), Richmond, Virginia, United States
Medical College of Wisconsin (Data Collection AND Data Analysis), Milwaukee, Wisconsin, United States
Contact Details
Name: Joseph Oved, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
